[Cognitive impairment in patients with metabolic syndrome. The current treatment possibilities]. / Vozmozhnosti terapii kognitivnykh narushenii u patsientov s metabolicheskim sindromom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 118(5): 18-22, 2018.
Article
in Ru
| MEDLINE
| ID: mdl-29927398
ABSTRACT
AIM:
To study the effect of therapy with cytoflavin on cognitive function in patients with metabolic syndrome (MS). MATERIAL ANDMETHODS:
The randomized controlled open study included 156 patients with MS. The mean age was 41.27±5.16 years. The duration of observation was 16 weeks. The main group of patients (n=78) received cytoflavin in the dose of 2 tablets 2 times a day. Patients in the control group (n=78) received basic therapy. All patients underwent neuropsychological testing at baseline, after 2 months and at the end of the study. Cognitive evoked potentials (Ð 300) were recorded to assess cognitive functions. The levels of plasma glucose and lipid profile were measured.RESULTS:
Cytoflavin improved cognitive functions. Two months after treatment, the results of neuropsychological testing and electrophysiological study were better in the main group compared to the control group.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Metabolic Syndrome
/
Cognitive Dysfunction
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
/
Middle aged
Language:
Ru
Journal:
Zh Nevrol Psikhiatr Im S S Korsakova
Journal subject:
NEUROLOGIA
/
PSIQUIATRIA
Year:
2018
Document type:
Article
Affiliation country:
Rusia